Welcome  |   Program  |  Registration  |   Hotel  |   Abstracts  |   Support Opportunities
9th Annual AACI Clinical Research Initiative Meeting


Efficient management is a mainstay of successful cancer clinical trials programs. Stimulating the timely staging of clinical trials for optimal patient benefit requires the development of standard trial management guidelines and robust methods of evaluation. AACI’s Clinical Research Initiative (CRI) aims to improve clinical trials management at cancer centers. To help achieve this goal, the CRI annual meeting provides opportunities for clinical trials office administrative directors and staff to share best practices – through peer-to-peer networking, collaboration and ongoing communication – that can lead to more effective cancer treatments.

CRI objectives include developing better methods for disseminating information across cancer centers, identifying and addressing clinical research challenges, and measuring progress. The CRI annual meeting program aligns with AACI's strategic goal of stimulating cancer center interactions to maximize the use of resources, including eliminating unproductive steps which slow down the drug development process. Those involved in CRI fill a variety of leadership roles and possess a comprehensive understanding of their centers entire clinical trials system.

This year’s meeting theme focuses on how AACI cancer centers are adapting to manage novel and complex cancer clinical research trials which advance cancer treatment and prolong patient survival.

Meeting Objectives:

1. Address cancer center challenges by working with novel research agents that can lead to the rapid development of new therapies.
2. Discuss how clinical trials office leaders are changing their operational structures to adapt to complex trial designs like the NCI Match Trial and basket and umbrella type trials.
3. Describe the impact of revisions to the NCI Cancer Center Support Grant guidelines, including how they affect preparations for NCI site visits.
4. Support peer-to-peer networking, collaboration and ongoing communications between clinical trials office administrative and medical directors.
5. Identify policies and practices that promote staff retention, job satisfaction, diversity and stability for the cancer center clinical research workforce.
6. Highlight challenges in preparing for audits and site monitoring visits.
7. Create trial budgets that address research staff effort while adhering to National Trial Coverage Decision Guidelines.
8. Discuss how cancer centers are building relationships with network care sites to promote trial accrual, coordination and monitoring to ensure study compliance and accurate research data collection that aligns with study endpoints.
9. Explore the use of information technology platforms to facilitate research data collection, electronic regulatory record management, and the capture of clinical trial finances.


Who Should Attend This Meeting?

• Administrative Directors of Clinical Trials Offices
• Clinical Trials Office Medical Directors
• Deputy/Associate Directors of Clinical Research Administration
• Administrative Directors of the Clinical Trials Office
• Cancer Center Administrators
• Clinical Trials Office Managers and Supervisors
• Research Regulatory Agency Organization Employees
• AACI Sustaining Members
• AACI Corporate Roundtable Members
• Representatives from industry including pharmaceutical companies and clinical research organizations